Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Mar 5;34(3):115-20.
doi: 10.1186/s40880-015-0003-0.

ATP-binding cassette subfamily B member 1 (ABCB1) and subfamily C member 10 (ABCC10) are not primary resistance factors for cabazitaxel

Affiliations

ATP-binding cassette subfamily B member 1 (ABCB1) and subfamily C member 10 (ABCC10) are not primary resistance factors for cabazitaxel

Rishil J Kathawala et al. Chin J Cancer. .

Abstract

Introduction: ATP-binding cassette subfamily B member 1 (ABCB1) and subfamily C member 10 (ABCC10) proteins are efflux transporters that couple the energy derived from ATP hydrolysis to the translocation of toxic substances and chemotherapeutic drugs out of cells. Cabazitaxel is a novel taxane that differs from paclitaxel by its lower affinity for ATP-binding cassette (ABC) transporters.

Methods: We determined the effects of cabazitaxel, a novel tubulin-binding taxane, and paclitaxel on paclitaxel-resistant, ABCB1-overexpressing KB-C2 and LLC-MDR1-WT cells and paclitaxel-resistant, ABCC10-overexpressing HEK293/ABCC10 cells by calculating the degree of drug resistance and measuring ATPase activity of the ABCB1 transporter.

Results: Decreased resistance to cabazitaxel compared with paclitaxel was observed in KB-C2, LLC-MDR1-WT, and HEK293/ABCC10 cells. Moreover, cabazitaxel had low efficacy, whereas paclitaxel had high efficacy in stimulating the ATPase activity of ABCB1, indicating a direct interaction of both drugs with the transporter.

Conclusion: ABCB1 and ABCC10 are not primary resistance factors for cabazitaxel compared with paclitaxel, suggesting that cabazitaxel may have a low affinity for these efflux transporters.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cytotoxicity of paclitaxel and cabazitaxel in ABCB1- and ABCC10-overexpressing cells. ABCB1, ATP-binding cassette subfamily B member 1; ABCC10, ATP-binding cassette subfamily C member 10. The cytotoxicity of paclitaxel and cabazitaxel was determined by the MTT assay in ABCB1-overexpressing KB-C2 and LLC-MDR1-WT cells, ABCC10-overexpressing HEK293/ABCC10 cells, and their parental KB-3-1, LLC-PK1, and HEK293/pcDNA3.1 cells. Error bars indicate the standard deviation (SD). Significantly elevated resistance of KB-C2 (A) and LLC-MDR1-WT cells (C) to paclitaxel, none or low-level resistance of KB-C2 (B) and LLC-MDR1-WT cells (D) to cabazitaxel, significantly elevated resistance of HEK293/ABCC10 cells to paclitaxel (E), and no resistance of HEK293/ABCC10 cells to cabazitaxel (F) are observed as compared with those of their parental cells.
Figure 2
Figure 2
Stimulation of ABCB1 ATPase activity by paclitaxel and cabazitaxel. Vanadate-sensitive ABCB1 ATPase activity was stimulated in the presence of the indicated concentrations of paclitaxel and cabazitaxel. Error bars indicate the SD.

Similar articles

Cited by

References

    1. Kathawala RJ, Sodani K, Chen K, Patel A, Abuznait AH, Anreddy N, et al. Masitinib antagonizes ATP-binding cassette subfamily C member 10-mediated paclitaxel resistance: a preclinical study. Mol Cancer Ther. 2014;13:714–23. doi: 10.1158/1535-7163.MCT-13-0743. - DOI - PMC - PubMed
    1. Yin S, Bhattacharya R, Cabral F. Human mutations that confer paclitaxel resistance. Mol Cancer Ther. 2010;9:327–35. doi: 10.1158/1535-7163.MCT-09-0674. - DOI - PMC - PubMed
    1. Kathawala RJ, Wang YJ, Ashby CR, Jr, Chen ZS. Recent advances regarding the role of ABC subfamily C member 10 (ABCC10) in the efflux of antitumor drugs. Chin J Cancer. 2014;33:223–30. doi: 10.5732/cjc.013.10122. - DOI - PMC - PubMed
    1. Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer. 2002;2:48–58. doi: 10.1038/nrc706. - DOI - PubMed
    1. Dumontet C, Sikic BI. Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death. J Clin Oncol. 1999;17:1061–70. - PubMed

Publication types